To include your compound in the COVID-19 Resource Center, submit it here.

Lilly CEO warns about effects of German healthcare reform

John Lechleiter, chairman, president and CEO of Eli Lilly and Co.

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE